Now that we're a month out from CES, these are the trends that have stuck with me. Yes, AI is on the list, of course, but so ...
The DVLA must be made aware of any condition that affects both eyes or one eye where you only have vision in that eye, or ...
News Medical on MSN3h
Vision loss risks in patients using popular GLP-1 medications raise concernsA small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...
The DVLA must be notified of eye conditions that affect you, with failure to disclose the condition risking a £1,000 fine ...
A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...
The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback